Laura R. Saunders

5.5k total citations · 1 hit paper
40 papers, 3.7k citations indexed

About

Laura R. Saunders is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Laura R. Saunders has authored 40 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 16 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Laura R. Saunders's work include Lung Cancer Research Studies (14 papers), Peptidase Inhibition and Analysis (8 papers) and Neuroendocrine Tumor Research Advances (7 papers). Laura R. Saunders is often cited by papers focused on Lung Cancer Research Studies (14 papers), Peptidase Inhibition and Analysis (8 papers) and Neuroendocrine Tumor Research Advances (7 papers). Laura R. Saunders collaborates with scholars based in United States, Germany and Japan. Laura R. Saunders's co-authors include Eric Verdin, Glen N. Barber, X. Peter, Carrie A. Grueter, Natacha Le Moan, Robert Stevens, Rafael de Cabo, Robert V. Farese, Christopher B. Newgard and John C. Newman and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Laura R. Saunders

39 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor

2012 1.3k citations Tadahiro Shimazu, Matthew D. Hirschey et al. Science profile →

Peers

Countries citing papers authored by Laura R. Saunders

Since Specialization

Citations

This map shows the geographic impact of Laura R. Saunders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura R. Saunders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura R. Saunders more than expected).

Fields of papers citing papers by Laura R. Saunders

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura R. Saunders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura R. Saunders. The network helps show where Laura R. Saunders may publish in the future.

Co-authorship network of co-authors of Laura R. Saunders

This figure shows the co-authorship network connecting the top 25 collaborators of Laura R. Saunders. A scholar is included among the top collaborators of Laura R. Saunders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura R. Saunders. Laura R. Saunders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of the DLL3-targeting Antibody–Drug Conjugate Rovalpituzumab Tesirine in Preclinical Models of Neuroblastoma 2022 ·Cancer Research Communications ·Kateryna Krytska, (unknown), Jennifer Pogoriler, Daniel Martínez, Komal S. Rathi, Alvin Farrel, Esther R. Berko, (unknown), (unknown), Nathan M. Kendsersky, Stephen W. Erickson, Beverly A. Teicher, Kumiko Isse, Laura R. Saunders, Malcolm A. Smith, John M. Maris, Yaël P. Mossé	5
2	Delivery of CRISPR/Cas9 Plasmid DNA by Hyperbranched Polymeric Nanoparticles Enables Efficient Gene Editing 2022 ·Cells ·Kemao Xiu, Laura R. Saunders, Luan Wen, Jinxue Ruan, Ruonan Dong, Jun Song, Dongshan Yang, Jifeng Zhang, Jie Xu, Y. Eugene Chen, X. Peter	15
3	Synthesis and Comparative In Vivo Evaluation of Site-Specifically Labeled Radioimmunoconjugates for DLL3-Targeted ImmunoPET 2021 ·Bioconjugate Chemistry ·Sai Kiran Sharma, Pierre Adumeau, Outi Keinänen, (unknown), Hetal Sarvaiya, (unknown), (unknown), Jacob Pourat, Kimberly J. Edwards, Ashwin Ragupathi, Omar Hamdy, Laura R. Saunders, Charles M. Rudin, John T. Poirier, Jason S. Lewis, Brian M. Zeglis	12
4	Rova-T enhances the anti-tumor activity of anti-PD1 in a murine model of small cell lung cancer with endogenous Dll3 expression 2020 ·Translational Oncology ·Philip Vitorino, Chen-Hua Chuang, Alexandre Iannello, Xi Zhao, Wade Anderson, Ronald E. Ferrando, Zhaomei Zhang, (unknown), Holger Karsunky, Laura R. Saunders	18
5	Delta-Like Protein 3 Expression and Targeting in Merkel Cell Carcinoma 2020 ·The Oncologist ·Hao Xie, Frederic J. Kaye, Kumiko Isse, Yan Sun, (unknown), Dorothy French, Thomas J. Flotte, Yan Luo, Laura R. Saunders, Aaron S. Mansfield	15
6	Biomimetic delivery of signals for bone tissue engineering 2018 ·Bone Research ·Ming Dang, Laura R. Saunders, Xufeng Niu, Yubo Fan, X. Peter	187
7	Suppressing mesenchymal stem cell hypertrophy and endochondral ossification in 3D cartilage regeneration with nanofibrous poly(l-lactic acid) scaffold and matrilin-3 2018 ·Acta Biomaterialia ·Qihai Liu, (unknown), Yupeng Chen, Zhanpeng Zhang, Laura R. Saunders, Ernestina Schipani, Qian Chen, X. Peter	46
8	P3.12-02 Dynamics of DLL3 and ASCL1 Expression in SCLC Over Disease Course 2018 ·Journal of Thoracic Oncology ·Anna F. Farago, Kumiko Isse, Benjamin J. Drapkin, Vashine Kamesan, Marina Kem, Laura R. Saunders, (unknown), Mari Mino–Kenudson	3
9	Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 Expression 2017 ·Clinical Cancer Research ·Timothy L. Lochmann, Konstantinos V. Floros, Mitra Naseri, Krista M. Powell, (unknown), Ryan J. March, Giovanna T. Stein, Patricia Greninger, (unknown), Laura R. Saunders, Scott J. Dylla, Carlotta Costa, Sosipatros A. Boikos, Joel Johansson, Andrew J. Souers, Geoffrey W. Krystal, Hisashi Harada, Cyril H. Benes, Anthony C. Faber	93
10	Preliminary safety and efficacy of rovalpituzumab tesirine in patients with delta-like protein 3-expressing advanced solid tumors 2017 ·Annals of Oncology ·Rahul Aggarwal, Aaron S. Mansfield, Himisha Beltran, Anna F. Farago, Christine L. Hann, (unknown), (unknown), Jiaxin Niu, Stephen Richey, David C. Smith, Heloisa P. Soares, Alexander I. Spira, Matthew H. Taylor, Saiama N. Waqar, Satwant Lally, M. Rossi, Laura R. Saunders, Scott J. Dylla, Edward Kavalerchik, Lowell Anthony	5
11	Prevalence of Delta-like protein 3 expression in patients with small cell lung cancer 2017 ·Lung Cancer ·Kentaro Tanaka, Kumiko Isse, (unknown), Mitsuhiro Takenoyama, Laura R. Saunders, Sheila Bheddah, Yoichi Nakanishi, Isamu Okamoto	87
12	Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor breakdown → 2012 ·Science ·Tadahiro Shimazu, Matthew D. Hirschey, John C. Newman, Wenjuan He, Kotaro Shirakawa, Natacha Le Moan, Carrie A. Grueter, (unknown), Laura R. Saunders, Robert Stevens, Christopher B. Newgard, Robert V. Farese, Rafael de Cabo, Scott M. Ulrich, Katerina Akassoglou, Eric Verdin	1329
13	Zmynd15 Encodes a Histone Deacetylase-dependent Transcriptional Repressor Essential for Spermiogenesis and Male Fertility 2010 ·Journal of Biological Chemistry ·Wei Yan, Yue Si, Sarah Slaymaker, Jiachen Li, Huili Zheng, David L. Young, Ara M. Aslanian, Laura R. Saunders, Eric Verdin, Israel Charo	53
14	Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs) 2007 ·Bioorganic & Medicinal Chemistry ·Stefan Schäfer, Laura R. Saunders, (unknown), Alfredo Velena, Mira Jung, Andreas Schwienhorst, (unknown), Achim Dickmanns, Ralf Ficner, (unknown), (unknown), (unknown), (unknown), (unknown)	59
15	Sirtuins: critical regulators at the crossroads between cancer and aging 2007 ·Oncogene ·Laura R. Saunders, Eric Verdin	473
16	Polyamines regulate sensitivity to HDAC inhibitor-induced apoptosis 2006 ·Cancer Research ·Laura R. Saunders, Eric Verdin	3
17	Adenosine Mimetics as Inhibitors of NAD⁺-Dependent Histone Deacetylases, from Kinase to Sirtuin Inhibition 2006 ·Journal of Medicinal Chemistry ·(unknown), A.M. Jochum, René Meier, Laura R. Saunders, Brett Marshall, Conrad Kunick, Eric Verdin, Peter G. Goekjian, Wolfgang Sippl, Manfred Jung	131
18	The 90- and 110-kDa Human NFAR Proteins Are Translated from Two Differentially Spliced mRNAs Encoded on Chromosome 19p13 2001 ·Genomics ·Laura R. Saunders, Vesna Jurecic, Glen N. Barber	34
19	Characterization of Two Evolutionarily Conserved, Alternatively Spliced Nuclear Phosphoproteins, NFAR-1 and -2, That Function in mRNA Processing and Interact with the Double-stranded RNA-dependent Protein Kinase, PKR 2001 ·Journal of Biological Chemistry ·Laura R. Saunders, Darren J. Perkins, Siddharth Balachandran, (unknown), (unknown), Akila Mayeda, Glen N. Barber	103
20	Mutations in RNA Polymerase II and Elongation Factor SII Severely Reduce mRNA Levels in Saccharomyces cerevisiae 1998 ·Molecular and Cellular Biology ·(unknown), (unknown), Laura R. Saunders, M. Benjamin Hock, Daniel Reines	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact